CLVax 1.0

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCLVax 1.0
Drug Alias Nameanti-influenza-T-cell vaccines(CureLab)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCurelab Oncology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCurelab Oncology
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A